Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predictive metabolite signatures for risk of progression to active TB from QuantiFERON supernatants of household contacts of TB patients.
Daniel EA, Upadhyay S, Selvachithiram M, Pattabiraman S, Bhanu B, Sivaprakasam A, Kulkarni V, Karyakarte R, Gaikwad S, Paradkar M, Yogendra Shivakumar SVB, Mave V, Gupta A, Prasad K, Hanna LE. Daniel EA, et al. Among authors: yogendra shivakumar svb. Emerg Microbes Infect. 2025 Dec;14(1):2437242. doi: 10.1080/22221751.2024.2437242. Epub 2024 Dec 22. Emerg Microbes Infect. 2025. PMID: 39628384 Free article.
Baseline IL-6 is a biomarker for unfavourable tuberculosis treatment outcomes: a multisite discovery and validation study.
Gupte AN, Kumar P, Araújo-Pereira M, Kulkarni V, Paradkar M, Pradhan N, Menon P, Padmapriyadarsini C, Hanna LE, Yogendra Shivakumar SVB, Rockwood N, Du Bruyn E, Karyakarte R, Gaikwad S, Bollinger R, Golub J, Gupte N, Viswanathan V, Wilkinson RJ, Mave V, Babu S, Kornfeld H, Andrade BB, Gupta A. Gupte AN, et al. Among authors: yogendra shivakumar svb. Eur Respir J. 2022 Apr 21;59(4):2100905. doi: 10.1183/13993003.00905-2021. Print 2022 Apr. Eur Respir J. 2022. PMID: 34711538 Free PMC article.
Correction: Smoking, alcohol use disorder and tuberculosis treatment outcomes: A dual co-morbidity burden that cannot be ignored.
Thomas BE, Thiruvengadam K, S R, Kadam D, Ovung S, Sivakumar S, Yogendra Shivakumar SVB, Paradkar M, Gupte N, Suryavanshi N, Dolla CK, Gupte AN, Kohli R, Pradhan N, Sivaramakrishnan GN, Gaikwad S, Kagal A, Dhanasekaran K, Deluca A, Golub JE, Mave V, Chandrasekaran P, Gupta A; CTRIUMPH-RePORT India Study. Thomas BE, et al. Among authors: yogendra shivakumar svb. PLoS One. 2019 Nov 1;14(11):e0224914. doi: 10.1371/journal.pone.0224914. eCollection 2019. PLoS One. 2019. PMID: 31675369 Free PMC article.